- Home
- ITUB vs GSK Comparison
ITUB vs GSK Comparison
Compare ITUB & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITUB | GSK |
|---|---|---|
| Founded | 1924 | 1715 |
| Country | Brazil | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.3B | 95.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ITUB | GSK |
|---|---|---|
| Price | $7.57 | $48.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $7.09 | N/A |
| AVG Volume (30 Days) | ★ 22.6M | 4.2M |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | ★ 5.19% | 3.43% |
| EPS Growth | 13.27 | ★ 118.57 |
| EPS | 0.77 | ★ 1.79 |
| Revenue | $25,400,232,630.00 | ★ $43,237,357,842.00 |
| Revenue This Year | $39.19 | $6.56 |
| Revenue Next Year | $6.89 | $5.13 |
| P/E Ratio | ★ $9.79 | $27.10 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $4.42 | $31.72 |
| 52 Week High | $8.13 | $49.31 |
Technical Indicators
Market Signals| Indicator | ITUB | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 57.86 |
| Support Level | $7.40 | $47.20 |
| Resistance Level | $8.13 | $49.31 |
| Average True Range (ATR) | 0.16 | 0.66 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 24.07 | 74.32 |
Price Performance
Historical ComparisonAbout ITUB Itau Unibanco Banco Holding SA (Each repstg 500 Preferred shares)
Itaú Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itaú and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itaú's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.